Education
About Us
Working with TipRanks
Follow Us
Selvita SA (PL:SLV)
:SLV
SLV Stock Chart & Stats
Day’s Range― - ―
52-Week Rangezł26.50 - zł62.40
Previous CloseN/A
VolumeN/A
Average Volume (3M)41.90K
Market Cap
zł693.84M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)1465.1
Beta0.73
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding18,355,474
10 Day Avg. Volume71,222
30 Day Avg. Volume41,898
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SLV FAQ
What was Selvita SA’s price range in the past 12 months?
Selvita SA lowest stock price was zł26.50 and its highest was zł62.40 in the past 12 months.
What is Selvita SA’s market cap?
Selvita SA’s market cap is zł693.84M.
When is Selvita SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Selvita SA’s earnings last quarter?
Currently, no data Available
Is Selvita SA overvalued?
According to Wall Street analysts Selvita SA’s price is currently Undervalued.
Does Selvita SA pay dividends?
Selvita SA does not currently pay dividends.
What is Selvita SA’s EPS estimate?
Selvita SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Selvita SA have?
Selvita SA has 18,355,474 shares outstanding.
What happened to Selvita SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Selvita SA?
Currently, no hedge funds are holding shares in PL:SLV
Company Description
Selvita SA
Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.